Nectar Lifesciences Limited

NSE:NECLIFE.NS

39.69 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Operating Activities:
Net Income 49.946-424.199340.8-594.53374.71588.2626.83674.38724.9847.54782.281,147.51854.321,204.381,152.99641.63827.52531.109456.589
Depreciation & Amortization 607.184591.189569.68602.53607.66632.57643.09622.51781.11765.57841.78759.49607.22460.96387.46303.07194.79115.77483.605
Deferred Income Tax 0000000000000000000
Stock Based Compensation 0000000000000000000
Change In Working Capital 688.667779.263-645.42-405.42703.6-131.93-1,607.19-203.26-969.92-1,192.93-163.13682.82-643.35-1,848.63-2,745.64235.05629.58-526.231-877.44
Accounts Receivables 0000000000000000000
Inventory 0000000000000000000
Accounts Payables 0000328.4200000000000000
Other Working Capital 688.667779.263-645.42-405.42375.18-131.93-1,607.18-203.35-615.18-1,192.93-163.13682.820000000
Other Non Cash Items 1,367.914390.261684.99611.211,163.631,303.51988.94893.931,097.591,023.921,087.861,018.51831.42604.66328.01-163.07-159.23-80.313-6.934
Operating Cash Flow 1,499.3431,336.514950.05213.792,849.62,392.35651.671,987.561,633.681,444.12,548.793,608.331,649.61421.37-877.181,016.681,492.6640.34-344.179
Investing Activities:
Investments In Property Plant And Equipment -294.152-300.601-249.7-312.41-547.7-381.27-331.63-533.77-780.35-805.03-1,015.82-1,206.01-2,589.53-1,983.7-1,418.99-2,093.71-1,344.54-1,741.532-682.358
Acquisitions Net 0797.88397.311.85185.2724.24.09283.530.7400000121.050024.0110
Purchases Of Investments 0-800.380-2.5-189.410-10-2.0800-200-201.26-6.4-2.42-17.272-99.731
Sales Maturities Of Investments 02.50-1.854.14001.29000051.88156.7517.230099.6460
Other Investing Activites 123.898817.63918.83128.67216.4295.7737.28352.7355.56209.7115.82218.46202.07157.1826.3311.68149.3-48.863108.147
Investing Cash Flow -294.152517.038166.441-286.24-331.28-261.3-294.35-181.04-726.87-595.33-900-989.55-2,335.58-1,669.77-1,455.67-1,788.43-1,197.66-1,684.01-673.942
Financing Activities:
Debt Repayment -1,182.93-1,060.96-505.69-1,246.46-1,246.88-534.89-7.26-880.47-0.14-508.13-920.76-1,638.31-2,273.12000-132.7100
Common Stock Issued 000000000000002,521.1303.39038.7
Common Stock Repurchased 0000000000000000-273.7200
Dividends Paid 000-11.21-13.54-13.5-13.5-26.99-22.47-22.43-22.43-22.43-22.430-53.29-60.9-29.770-25.903
Other Financing Activities -1,338.361-794.871-688.111,372.57-1,258.25-1,462.5-375.26-1,133.72-851.55-592.29-668.23-1,154.892,915.021,226.25-131.84919.5838.331,741.461,151.649
Financing Cash Flow -1,182.931-1,855.831-1,193.8114.9-2,518.67-2,010.89-396.02-2,041.18-874.16-614.72-1,611.42-2,815.63619.471,226.252,336858.68-394.481,741.461,164.445
Other Information:
Effect Of Forex Changes On Cash 0-0.001-0.00100.020000-0.010.010000.010000
Net Change In Cash 22.26-2.279-77.3142.45-0.34120.16-38.7-234.6632.65234.0437.38-196.85-66.5-22.153.1686.93-99.4897.79146.324
Cash At End Of Period 198.06175.8178.08255.39212.93213.2793.11131.81366.47333.8299.7862.4259.25325.75347.9347.27260.34359.816262.026